Last Posted: Aug 10, 2019
- Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions
E Merkan et al, JAMA Network Open, August 9,2109 - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
BR McDonald et al, Science Translational Medicine, August 7, 2019 - A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
Shimizu Hideyuki et al. EBioMedicine 2019 Jul - Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation.
Kotsopoulos Joanne et al. JAMA network open 2019 Aug 2(8) e198420 - Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy.
Shimomura Akihiko et al. Translational oncology 2019 Aug 12(10) 1386-1394 - Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
Terkelsen Thorkild et al. Acta oncologica (Stockholm, Sweden) 2019 Aug 1-6 - Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay.
Desai Neelam V et al. Breast cancer research : BCR 2018 20(1) 75 - miRNA profile obtained by next?generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.
Martinez-Gutierrez Antonio Daniel et al. International journal of molecular medicine 2019 Jul - Research participants' experiences with return of genetic research results and preferences for web-based alternatives.
Gaieski Jill B et al. Molecular genetics & genomic medicine 2019 Aug e898 - Automating artificial intelligence for medical decision-making
R Matheson, MIT News, August 6, 2019
No hay comentarios:
Publicar un comentario